Rohann Correa retweeted
Kidney SABR on the front cover of @TheLancetOncol. A well-deserved recognition for @_ShankarSiva for his work and efforts over the past 10+ years.
thelancet.com/journals/lanon…
Rohann Correa retweeted
Not one but two oncology Oscar’s. @QuadShotNews two papers mentioned in this week addition
@NicholasZaorsky @_ShankarSiva @SimonLo21054188 @drviviantan @DrCorreaRO
Rohann Correa retweeted
In this new #RedJournal article, IROCK Contouring Guidelines now available for Renal SABR! tinyurl.com/rjadhar
Rohann Correa retweeted
Some great news!
@DrOlsonOncology ‘s SABR-COMET-3 completed accrual today!!
330 randomized with 1-3 Mets, primary endpoint OS.
Biomarker studies led by @DrAlisonAllan and @DrCorreaRO.
Readout maybe in 2027, with COMET10 likely in 2026.
Rohann Correa retweeted
sciencedirect.com/science/ar…
A recent analysis from IROCK in press. This time looking at outcomes for clear vs non-clear cell RCCs
@_ShankarSiva @PeterMacRadOnc @DrCorreaRO @NicholasZaorsky
Rohann Correa retweeted
Replying to @SimonLo21054188 @LPonsky @drviviantan @_ShankarSiva @DrAlexLouie @NicholasZaorsky @spsutkaMD @DrCorreaRO @ChadTangMD @Raquib_Hannan @MichaelStaehler @AMuacevic @VedangMurthy
IROCK has certainly made great progress!
This map always feels out of date as we seem to activate a site each week but it show the expansion over the last few years.
Rohann Correa retweeted
"Oligo"-no more! 🇨🇦ARREST phase I out now @IJROBP - @sueyom
➡️SABR to median=16 "poly"metastases in patients who had already exhausted multiple lines of systemic therapy
➡️4x dose levels (up to 6Gyx5).
➡️No safety signals, QoL maintained. shorturl.at/gStwt Congrats! 👏👏
Congratulations Nick!
Protecting kidney function after local renal cell carcinoma therapy
Interview @UrologyTimes #ASTRO24 @ASTRO_org
urologytimes.com/view/nichol…
@crajoulh @_ShankarSiva @mwang_cwru @DrAlexLouie @ASwaminathMD @EricLehrer @angela_jia_ @DrCorreaRO @SimonLo21054188 @DrSpratticus @LPonsky
6
340
Thank you Dr. @LauraBukavinaMD & @DrVitagliano for running this excellent, multi-disciplinary session! Glad to share evidence generated by @_ShankarSiva @Raquib_Hannan @DrAlexLouie @NicholasZaorsky @SimonLo21054188 & many other colleagues! #IROCK
Replying to @DrCorreaRO
@DrCorreaRO reviews the indications and outcomes of SBRT in T1 tumors, highlighting the evolving perspectives on radiation therapy and its results. We are all excited to see more in the near future @SIU_urology #SIU2024NewDelhi
Rohann Correa retweeted
Replying to @DrCorreaRO
@DrCorreaRO reviews the indications and outcomes of SBRT in T1 tumors, highlighting the evolving perspectives on radiation therapy and its results. We are all excited to see more in the near future @SIU_urology #SIU2024NewDelhi
Rohann Correa retweeted
@ASTRO_org 2024 will mark the 10th Anniversary for IROCK with hopefully decades to come! @_ShankarSiva @DrAlexLouie @MellyB_7 @DrCorreaRO @NicholasZaorsky
Rohann Correa retweeted
Stereotactic Body Radiotherapy for Primary Renal Cell Carcinoma: A Case-Based Radiosurgery Society Practice Guide - ScienceDirect sciencedirect.com/science/ar…
Rohann Correa retweeted
The @OncoAlert 🚨Newsletter NOW OUT
Covering July 5-11. 2024
REGISTER at Oncoalert360.com or oncoalert.m-pages.com/nhMpwe…
Discussing:
✅UNICANCER-PRODIGE23🧪 in #RectalCancer
✅Renal function after SABR in 1ry #KidneyCancer
@drviviantan @DrAlexLouie
@DrCorreaRO @_ShankarSiva
✅Resistance Oncogenic KRASinh #PancreaticCancer
✅PDL1& Nectin4 expression in #BladderCancer out on @JournalCancer
✅Resistance of EGFR TKIs #LungCancer #NSCLC 🫁
✅SWOG1216 🇺🇸 @ggebraelmd @neerajaiims
✅Dose Relation of Exercise & Distant Recurrence in 1ry #BreastCancer🏃♀️
@matteolambe @Icro_Meattini @seanmmcbride @HenningWillers
@montypal @crisbergerot @DrDanielHeng @apolo_andrea @DrChoueiri @PGrivasMDPhD @TiansterZhang @amerseburger @sonpavde @drenriquegrande @scserendipity1
@EfstathiouEleni @DrYukselUrun
@Aiims1742 @CathyEngMD @marklewismd @ARosen380 @GillSharlene @BenWestphalen
#OncoAlertAF
@nataliagandur @acampsmalea @MartaPerachino @BiagioRicciutMD @DenizCanGuven1
@yekeduz_emre @HHorinouchi @FadiHaddad_MD
@Dr_Ivanoncologo @Abdallah81MD @FernandoOnco
@ElisaAgostinett @dr_yakupergun @to_be_elizabeth @anmwongNZ @lungoncdoc @ADesaiMD @bavilima @realbowtiedoc
Rohann Correa retweeted
🔥Hot off the press @EurUrolOncol
IROCK 🇨🇦🇦🇺🇺🇸🇩🇪🇯🇵 demonstrating #SABR ⚡️yields moderate long-term renal function decline, low dialysis rates even in patients with a solitary kidney #radonc
authors.elsevier.com/c/1jOzs…
Thankful for mentors @_ShankarSiva
@DrAlexLouie @DrCorreaRO
Congratulations to fellow presenters @MdStephans @Rrkotecha for such excellent talks & to the #ISRSUSA2024 @ISRSy attendees for super-insightful questions!
Star studded group reviewing SBRT for oligometastatic disease. @DrCorreaRO @MdStephans @Rrkotecha speaking and Dr. Amol Ghia and @MichaelTMilano moderating. #SBRT being discussed at @ISRSy #ISRSUSA2024 Congress
9
602
🙏🏽🙏🏽 @bslotman Great to see you again and I was proud to give a well-deserved nod of appreciation to immune analysis expert Dr. @SchneidersFamke & @amsterdamumc - collaborative studies are ongoing!
Replying to @DrCorreaRO
1
15
924
Rohann Correa retweeted
Replying to @DrCorreaRO
Rohann Correa retweeted
Good catch-up and moderating @ISRSy #ISRSUSA2024 GU prostate SABR session with @DrCorreaRO, co-fellows @Sunnybrook @UofTDRO @DrAndrewLoblaw
Excellent GU abstracts presented @ISRSy #ISRSUSA2024 Congress. #SBRT @DrCorreaRO and @weeloonong moderating.
This novel study with @DropletBiosci is open & accruing steadily thanks to 💪🏽💪🏽 collaboration with colleagues @WesternOtoHNS! Not possible without mentors/collaborators @drdavidpalma @nicholslab1 @jpzevallos @aadel_chaudhuri & many others 🙏🏽🙏🏽
Thrilled to be working with @DropletBiosci and @DrCorreaRO head and neck cancer research projects!! @WesternOtoHNS @SchulichMedDent





































